Venturi Wealth Management LLC Boosts Position in Astera Labs, Inc. $ALAB

Posted by Francis Steltz on Jun 29th, 2026

Venturi Wealth Management LLC raised its position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 105.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,738 shares of the company’s stock after acquiring an additional 3,454 shares during the quarter. Venturi Wealth Management LLC’s holdings in Astera Labs were worth $738,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of ALAB. Vanguard Group Inc. grew its stake in shares of Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after acquiring an additional 84,365 shares during the period. State Street Corp raised its stake in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after acquiring an additional 760,358 shares during the period. Geode Capital Management LLC lifted its holdings in Astera Labs by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares in the last quarter. Fred Alger Management LLC lifted its holdings in Astera Labs by 25.5% during the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after purchasing an additional 393,250 shares in the last quarter. Finally, Morgan Stanley boosted its position in shares of Astera Labs by 33.0% in the fourth quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock worth $321,818,000 after purchasing an additional 480,009 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have issued reports on ALAB. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Needham & Company LLC upped their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Stifel Nicolaus increased their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Finally, Susquehanna lifted their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $254.75.

View Our Latest Analysis on Astera Labs

Insider Activity at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $1,277,046.75. Following the completion of the sale, the director directly owned 60,134 shares in the company, valued at $21,909,822.90. This trade represents a 5.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the transaction, the general counsel directly owned 103,343 shares of the company’s stock, valued at $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 2,161,942 shares of company stock worth $460,115,294 in the last ninety days. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $391.74 on Monday. Astera Labs, Inc. has a 1-year low of $85.85 and a 1-year high of $440.99. The business’s 50 day moving average is $289.20 and its two-hundred day moving average is $196.24. The stock has a market capitalization of $67.15 billion, a P/E ratio of 264.69, a PEG ratio of 4.50 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period last year, the company earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.